TrialClinical rheumatology2017

Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study.

Tatsuo Hosoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.